AMSTERDAM—Philips will pay $1.1 billion to settle the personal injury litigation and the medical monitoring class action lawsuit to end the uncertainty associated with litigation in the U.S.
AMSTERDAM—Philips Respironics announced the discontinuation of 19 sleep and respiratory products in the United States with a shift in focus to the sale of consumables and accessories, including masks.
WATERLOO, Iowa & LONDON (August 2, 2022)—Belluscura, a medical device developer focused on lightweight and portable oxygen enrichment technology, announces that it has entered into a Group Purchasing Organization Product Supply Agreement for the supply of portable oxygen concentrators with VGM Group, Inc.
BALL GROUND, GA (May 5, 2022)—Global oxygen equipment manufacturer CAIRE Inc. will be expanding its portfolio of solutions in Latin America this summer. The Companion 5 and NewLife Intensity 10 stationary oxygen concentrators are expected to launch in July, following an anticipated approval by the Brazilian Health Regularity Agency (Anvisa).
BIRMINGHAM, Alabama (January 27, 2022)—The Food and Drug Administration has expanded Philips Respironics’ product recall, adding the Trilogy Evo ventilator and muffler repair kits to the list—and declared it a level 1 recall, the most severe.
